PERSPECTA

News from every angle

← Back to headlines

Eli Lilly's Retatrutide Shows Broad Benefits for Obesity and Sleep Apnea

Eli Lilly announced that its experimental obesity drug, retatrutide, demonstrated broad benefits, including significant weight loss and improvement in sleep apnea symptoms, during its latest trials.

6 Jun, 18:33 — 6 Jun, 18:33
PostShare

Sources

Showing 1 of 2 sources
YahooMostly Factual4h ago

Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits

Read full article →

Coverage Timeline

First report: Yahoo · 6 Jun, 18:33Full coverage: 2 · 3hWindow: 3h
Left-leaningCenterRight-leaning
Yahoo6 Jun, 18:33First to report

Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits

3h later
seeking-alpha6 Jun, 21:37Latest update

Eli Lilly reports broad benefits for experimental obesity drug retatrutide

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

School Supply Prices Stable in the Philippines

just now

NFA Bukidnon Prepares 20,000 Bags of Rice for Auction

just now

AI-Generated Real Estate Photos Cause Misleading Listings in Finland

13m ago